Physiological and Thermoregulatory Responses of Body Cooling During Cycling in a Hot Environment
Launched by UNIVERSITY OF CONNECTICUT · Jan 14, 2021
Trial Information
Current as of June 16, 2025
Completed
Keywords
ClinConnect Summary
Design
The study will be completed in the following timeline:
Visit 1: Baseline and VO2max Testing
Vist 2: Metabolic Heat Production Visit
Visit 3-6: Trial 1, 2 ,3, 4
Visit specific information is described below, however, specific data collection protocols for dependent variables and procedures are included below the description of the study design. Participants will be asked to sign a photo/video release form (Appendix H) to be used in research projects, scientific publications/conferences and for educational purposes. Participants may be videoed or photographed while exercising or r...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Cisgender man between the ages of 18-28 years
- • been cleared by the medical monitor for this study
- • VO2max \> 45ml/kg/min
- • Aerobically active (at least 30 minutes of aerobic exercise 4-5 days per week)
- Exclusion Criteria:
- • Have a current musculoskeletal injury that would limit their physical activity or preclude the participant from walking, jogging, running, sprinting, or cutting.
- • Chronic health problems that affect your ability to thermoregulate (disorders affecting the liver, kidneys or the ability to sweat normally)
- • Fever or current illness at the time of testing
- • History of cardiovascular, metabolic, or respiratory disease
- • A family member died for no apparent reason, had a heart attack, died from heart problems, or sudden death before the age of 50
- • Current musculoskeletal injury that limits their physical activity
- • Currently taking a medication that is known to influence body temperature (amphetamines, antihypertensives, anticholinergics, acetaminophen, diuretics, NSAIDs, aspirin)
- • Identify as cisgender woman, transgender man or transgender woman. Cisgender women, Transgender men, and transgender women are excluded from the current study because the sponsor of the study has requested that this testing be done in physically active cisgender males. It is assumed that they either currently have data on women or transgender women/men to compare this to or have a strategic initiative from a marketing or business perspective that only involves cisgender men.
- • Have a history of heat related illness
- • Throat or gastroesophageal diseases including gastroesophageal reflux disease (aka, GERD) or difficulty swallowing
- • Have any allergies or adverse reactions to the cold (e.g. Cold Uticaria, Raynauds Phenomenon/Disease, or Cryoglobulinanemia)
About University Of Connecticut
The University of Connecticut (UConn) is a leading academic institution committed to advancing health and science through innovative research and education. As a clinical trial sponsor, UConn leverages its extensive resources, including renowned faculty and state-of-the-art facilities, to conduct rigorous studies that contribute to medical knowledge and improve patient care. The university fosters a collaborative environment, engaging multidisciplinary teams to explore novel therapies and interventions across various health-related fields. UConn's dedication to ethical practices and compliance ensures the integrity and reliability of its clinical research, ultimately aiming to enhance health outcomes and address critical challenges in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Storrs, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials